Short-term treatment with taurolidine is associated with liver injury

Abstract Background Taurolidine has been used for peritonitis, oncological and catheter-lock treatment because of its anti-inflammatory properties. It has been suggested that taurolidine has no severe side-effects, but after long-term use morphological and functional changes of the liver were report...

詳細記述

書誌詳細
主要な著者: René Fahrner, Anika Möller, Adrian T. Press, Andreas Kortgen, Michael Kiehntopf, Falk Rauchfuss, Utz Settmacher, Alexander S. Mosig
フォーマット: 論文
言語:English
出版事項: BMC 2017-08-01
シリーズ:BMC Pharmacology and Toxicology
主題:
オンライン・アクセス:http://link.springer.com/article/10.1186/s40360-017-0168-z